Sökning: WFRF:(Gottlieb Sami L.)
> (2023) >
Vaccine value profi...
Vaccine value profile for Neisseria gonorrhoeae
-
- Lyu, Yiming (författare)
- University of Melbourne, Parkville, Australia
-
- Choong, Annabelle (författare)
- Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia
-
- Chow, Eric P. F. (författare)
- Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia; Melbourne Sexual Health Centre, Alfred Health,, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
-
visa fler...
-
- Seib, Kate L. (författare)
- Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia
-
- Marshall, Helen S. (författare)
- The University of Adelaide, Adelaide, South Australia, Australia; Women's and Children's Health Network, North Adelaide, South Australia, Australia
-
- Unemo, Magnus, 1970- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,WHO CC for Gonorrhoea and Other STIs, Örebro University, Örebro, Sweden; Institute for Global Health, University College London (UCL), London, UK
-
- de Voux, Alex (författare)
- Division of Epidemiology and Biostatistics, Faculty of Health Sciences, University of Cape Town, Rondebosch, Cape Town, South Africa
-
- Wang, Bing (författare)
- The University of Adelaide, Adelaide, South Australia, Australia; Women's and Children's Health Network, North Adelaide, South Australia, Australia
-
- Miranda, Angelica E. (författare)
- Department of Social Medicine, Universidade Federal do Espirito Santo, Goiabeiras, Vitória, Brazil
-
- Gottlieb, Sami L. (författare)
- Department of Sexual and Reproductive Health and Research, World Health Organization, Genève, Switzerland
-
- Mello, Maeve B. (författare)
- Global HIV, Hepatitis and STI Programmes, World Health Organization, Genève, Switzerland
-
- Wi, Teodora (författare)
- Global HIV, Hepatitis and STI Programmes, World Health Organization, Genève, Switzerland
-
- Baggaley, Rachel (författare)
- Global HIV, Hepatitis and STI Programmes, World Health Organization, Genève, Switzerland
-
- Marshall, Caroline (författare)
- Department of Immunization, Vaccines and Biologicals, World Health Organization, Genève, Switzerland
-
- Abu-Raddad, Laith J. (författare)
- Weill Cornell Medicine-Qatar, Qatar Foundation - Education City, Doha, Qatar
-
- Abara, Winston E. (författare)
- Centers for Disease Control and Prevention, Atlanta, USA
-
- Chen, Xiang-Sheng (författare)
- National Center for STD Control of China CDC, Nanjing, China
-
- Ong, Jason J. (författare)
- Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: Vaccine. - : Elsevier. - 0264-410X .- 1873-2518.
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Neisseria gonorrhoeae infection (gonorrhoea) is a global public health challenge, causing substantial sexual and reproductive health consequences, such as infertility, pregnancy complications and increased acquisition or transmission of HIV. There is an urgency to controlling gonorrhoea because of increasing antimicrobial resistance to ceftriaxone, the last remaining treatment option, and the potential for gonorrhoea to become untreatable. No licensed gonococcal vaccine is available. Mounting observational evidence suggests that N. meningitidis serogroup B outer membrane vesicle-based vaccines may induce cross-protection against N. gonorrhoeae (estimated 30%-40% effectiveness using the 4CMenB vaccine). Clinical trials to determine the efficacy of the 4CMenB vaccine against N. gonorrhoeae are underway, as are Phase 1/2 studies of a new gonococcal-specific vaccine candidate. Ultimately, a gonococcal vaccine must be accessible, affordable and equitably dispensed, given that those most affected by gonorrhoea are also those who may be most disadvantaged in our societies, and most cases are in less-resourced settings. This vaccine value profile (VVP) provides a high level, holistic assessment of the current data to inform the potential public health, economic and societal value of pipeline vaccines. This was developed by a working group of subject matter experts from academia, non-profit organizations, public private partnerships and multi-lateral organizations. All contributors have extensive expertise on various elements of the N. gonorrhoeae VVP and collectively aimed to identify current research and knowledge gaps. The VVP was developed using published data obtained from peer-reviewed journals or reports.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Nyckelord
- Gonorrhoea
- Infertility
- Neisseria gonorrhoeae
- OMV MenB vaccines
- Sexually transmitted infection
- Vaccine
- Value profile
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Vaccine
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Lyu, Yiming
-
Choong, Annabell ...
-
Chow, Eric P. F.
-
Seib, Kate L.
-
Marshall, Helen ...
-
Unemo, Magnus, 1 ...
-
visa fler...
-
de Voux, Alex
-
Wang, Bing
-
Miranda, Angelic ...
-
Gottlieb, Sami L ...
-
Mello, Maeve B.
-
Wi, Teodora
-
Baggaley, Rachel
-
Marshall, Caroli ...
-
Abu-Raddad, Lait ...
-
Abara, Winston E ...
-
Chen, Xiang-Shen ...
-
Ong, Jason J.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Infektionsmedici ...
- Artiklar i publikationen
-
Vaccine
- Av lärosätet
-
Örebro universitet